Search for: "In Re Ar" Results 2121 - 2140 of 2,308
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2008, 9:15 am
” More bad news for the Swiss Giant, but the bank need not feel alone at the ARS Party. [read post]
28 Jul 2008, 1:01 pm
Einer entsprechenden Anwendung dieser Regelung steht - so der Bundesgerichtshof - entgegen, dass Kopierstationen, die schon wegen ihres hohen Anschaffungspreises praktisch ausschließlich von Unternehmen zu gewerblichen Zwecken erworben und genutzt werden, nur wesentlich seltener als die von der Regelung erfassten Fotokopiergeräte für die vom Gesetz ausdrücklich zugelassenen… [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas), Three-strikes scheme… [read post]
18 Jul 2008, 3:46 pm
In short, we’re looking at a future with more non-local programming and more local programming. [read post]
16 Jul 2008, 5:52 am
Hier stehen sich zwei Überlegungen gegenüber. [read post]
15 Jul 2008, 3:23 am
Personally, if we're going to start playing the "What If? [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
5 Jul 2008, 11:05 am
’: (IP finance), Allied Security Trust – High-tech companies pool resources to fight trolls: (IAM), (Techdirt), (Patent Prospector), (Ars Technica), (Technological Innovation and Intellectual Property) Global - Copyright On distinguishing between creative commons, the public domain, and all rights reserved – confusion in mainstream media: (creativecommons.org), Inside views: a new business model for the music industry explained: (Intellectual Property Watch),… [read post]
27 Jun 2008, 12:52 pm
We're winning this War on Terror. [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
26 Jun 2008, 10:00 pm
Ars Technica's Jacqui Cheng offers one of the rare insightful stories on the subject: "What we're effectively doing is opening up huge amounts of online real estate," ICANN president and CEO Paul Twomey told the Wall Street Journal before the vote took place. [read post]
23 Jun 2008, 3:34 am
CANADA AND TERRORISM: We're so polite that we can't see a danger hiding in plain sight: You know what is the really sobering thing about that ongoing terror trial in Brampton? [read post]
21 Jun 2008, 12:26 pm
The has been enough coverage that it seems unnecessary to rehearse all the commentary; there is a story at Ars Technica here, and one from the Electronic Frontier Foundation here. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
18 Jun 2008, 8:32 am
Este cuadro muestra los diferentes escenarios: las retenciones fijas de 2007 (35 % a cualquier precio, Res. 369/07), las retenciones móviles "originales" del 10 de marzo (Res. 125/08), las retenciones según la modificación vigente a partir del 30 de mayo (Res. 64/08). [read post]
17 Jun 2008, 12:38 pm
Aber wenn sich dies privatrechtlich realisiert, wer weiß, wie die Gerichte entscheiden werden? [read post]